Atlas Trials

Korea Post Marketing Surveillance (PMS) Study of Vizimpro

Clinical trial NCT04721106 · COMPLETED

Trial details

NCT number
NCT04721106
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Lung Neoplasms
Start date
2021-03-07
Primary completion
2026-01-19
Enrollment
188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.